<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The bcl-2 proto-oncogene encodes a protein that protects cells from programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> (<z:mpath ids='MPATH_3'>apoptosis</z:mpath>) </plain></SENT>
<SENT sid="1" pm="."><plain>High levels of this protein confer a growth advantage to neoplastic cells even in the absence of a high mitotic rate </plain></SENT>
<SENT sid="2" pm="."><plain>This gene is involved in the interchromosomal 14;18 translocation, an abnormality present in more than two-thirds of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and in about 25% of other non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the lymph nodes </plain></SENT>
<SENT sid="3" pm="."><plain>A recent study also demonstrated the presence of high levels of bcl-2 protein in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> such as <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> of the lung and related it to a better prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed bcl-2 protein expression in 20 cases each of basal- and <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo> and in 5 biopsy specimens of <z:mpath ids='MPATH_458'>normal</z:mpath> skin, using a monoclonal anti-bcl-2 protein antibody with a standard 3-step immunoperoxidase technique on routinely fixed, paraffin-embedded tissue sections </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> skin showed positive staining of the majority of keratinocytes in the epidermal basal layer </plain></SENT>
<SENT sid="6" pm="."><plain>Bcl-2 positivity was also observed within the outer root sheath and the mesenchymal cells of the follicular papillae, the clear cells of the eccrine glands, and in some melanocytes at the dermo-epidermal junction </plain></SENT>
<SENT sid="7" pm="."><plain>Neoplastic cells in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:hpo ids='HP_0002671'>basal-cell carcinoma</z:hpo> showed a positive cytoplasmic reaction for bcl-2 </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> biopsy specimens of <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo> were negative </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of bcl-2 protein could also be observed in the majority of peri- and intratumoral lymphocytes in both <z:hpo ids='HP_0002671'>basal-cell carcinoma</z:hpo> and <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>